Stem cell research will continue to be debated in halls of Congress but unfortunately, political decisions might not line up with sound science.
As the 111th session of Congress begins, a top priority for the new administration and some members of Congress will be to revisit President George W. Bush’s policy limiting federal funding for embryonic stem cell research (ESCR). The policy has been the center of Congressional debate since 2001 — but each year more and more of the scientific discussion focuses on the development of alternatives to destroying human embryos for stem cell research.
Based on a number of recent groundbreaking studies using non-embryonic sources, we can only hope this ethical research to take more of center stage in the 2009 Congressional debate.
In many ways, pro-ESCR politicians have painted themselves into a corner. In an effort to gain widespread support for ESCR, they — along with some willing scientists — made some high level promises to the American people. The story line went like this:
But, so far, embryonic stem cells have failed to fulfill any of these promises.
Why Not Embryonic Stem Cell Research?
The public promotion of ESCR is by no means at a stand-still. ESCR is the subject of frequent and overly-hyped press releases that usually consist of exclamations about great “breakthroughs.” What these releases fail to mention is that at least one of three limitations calls into question virtually all of these ESCR “successes:” 1) scientists are experimenting in animals (never humans because it’s too risky) 2) immune rejection problems or cancer-causing tendencies are always an issue, and 3) research normally entails making embryonic stem cells behave like adult stem cells (rather ironic if you think about the strides being made with adult stem cells).
Proponents of ESCR continue to run into dead ends with these cells. New animal studies identify the same significant hurdles of previous research. As long as embryonic stem cells are rejected by patients and replicate wildly, causing cancer, there is little potential for these cells to treat disease.
In addition to the practical problems that continue to plague ESCR, obvious moral problems exist. Embryonic stem cells are harvested from a young human embryo and as a result, that embryo is destroyed. And this process – or anything that destroys, harms, or puts human life at risk – is contrary to the sacredness and value of human life.
When we consider how God designed the human body to function, it should come as no surprise that scientists continue to encounter problems with embryonic stem cells. A human life at the embryonic stage of development is on a fast-track to becoming a fully formed human being. In order to develop all the cells, tissues and organs necessary for the human body to function, embryonic stem cells divide and specialize rapidly. So it makes sense that these cells, when taken out of God's natural order, would replicate too quickly and form tumors. In contrast, cells in a fully formed body are replenished and rejuvenated during the natural wear and tear of life – by adult stem cells. So, it’s no surprise that the adult stem cells God designed to heal our bodies are the most successful in stem cell treatments and therapies. These stem cells also pose no ethical concerns, making them ideal for these purposes.
Adult Stem Cell Success
Fortunately, not all scientists have jumped on the ESCR bandwagon. Some scientists continue to move forward with morally acceptable stem cell research. These cells – often referred to as adult stem cells – have been successfully treating patients for more than a decade. In fact, more than 70 diseases and conditions are being treated with these cells. Even the federal government recognizes the importance of research with these cells – more than 2100 clinical trials with adult stem cells are being funded by the National Institutes of Health, with more added every day.
The Pentagon also understands the unique therapeutic potential of ethical stem cells. They are investing a quarter-billion dollars into adult stem cell research to help service members and war veterans injured on the battlefield.
Col. Bob Vandre of the Army’s Medical Research and Material Command launched this five-year initiative that will use patients’ stem cells to stop scarring, rebuild tendons and grow new ones. He believes that “regenerative medicine is going to change the world.” He understands that it will be the means for "increasing the quality of lives, and [become] a huge technology that’ll completely change the way we do medicine throughout the country.”
There is a clear reason that this multi-million dollar initiative focuses on adult stem cells: Unlike embryonic stem cells, adult stem cells have a proven track record, with a steady stream of new examples almost every week. Here are a few recent success stories:
The list continues to grow — evidence that adult stem cell research isn’t theoretical; these are real therapies, helping real patients.
Looking Ahead
Not only are the traditional forms of adult stem cells continuing to help patients, scientists are discovering other helpful alternatives to destructive research. The newest research uses ordinary adult body cells and transforms them into the embryonic-like stem cell research without harming human life. To learn more about iPS cells and this research, please visit Looking Forward: Ethical Stem Cell Research.
Unfortunately, a new administration and Congress might night make decisions based on sound scientific research. So what should members of Congress consider when they debate this issue in the coming months?
Morally problematic, life destroying embryonic stem cell research is losing ground as a viable option for research and treating disease. In fact, some scientists have gone so far as to say ESCR is on its way to becoming obsolete. That’s some intellectual honesty that is nice to report.
In stark contrast to the failures of ESCR, ethically and scientifically sound non-embryonic stem cell research is providing real therapies. And basic research with adult cells continues to show promise for even more ways to obtain new, ethical, and useful stem cells.
The reality is that while science is leading researchers down a more ethical path, none of this would have been possible if pro-life voices had not persevered in their call for ethical research. The morally acceptable research we see today is a testimony to those voices – and to President George W. Bush who stood strong in his defense of human life by putting a limit on federal funding for embryo-destroying research.
If you enjoy reading stories like this one, sign up for the free CitizenLink Daily Update e-mail. You'll get news and commentary from Focus on the Family Action delivered right to your computer.